BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiese AD, Griffin MR, Zhu Y, Mitchel EF Jr, Grijalva CG. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine 2016;34:6243-9. [PMID: 27832918 DOI: 10.1016/j.vaccine.2016.10.062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Fitzgerald D, Waterer GW. Invasive Pneumococcal and Meningococcal Disease. Infectious Disease Clinics of North America 2019;33:1125-41. [DOI: 10.1016/j.idc.2019.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Slaats MA, De Dooy J, Van Hoorenbeeck K, Van Schil PEY, Verhulst SL, Hendriks JMH. A combined intrapleural administration of dornase alfa and tissue plasminogen activator is safe in children with empyema - A pilot study. Acta Chir Belg 2021;121:184-8. [PMID: 31750793 DOI: 10.1080/00015458.2019.1696516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Forster J, Piazza G, Goettler D, Kemmling D, Schoen C, Rose M, Streng A, Liese JG. Effect of Prehospital Antibiotic Therapy on Clinical Outcome and Pathogen Detection in Children With Parapneumonic Pleural Effusion/Pleural Empyema. Pediatr Infect Dis J 2021;40:544-9. [PMID: 33395211 DOI: 10.1097/INF.0000000000003036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. The Lancet 2020;396:786-98. [DOI: 10.1016/s0140-6736(20)31550-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
5 Liese J, Schoen C, van der Linden M, Lehmann L, Goettler D, Keller S, Maier A, Segerer F, Rose M, Streng A. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010–2017: a nationwide surveillance study. Clinical Microbiology and Infection 2019;25:857-64. [DOI: 10.1016/j.cmi.2018.10.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
6 Benedictis FM, Carloni I. Management of necrotizing pneumonia in children: Time for a patient‐oriented approach. Pediatr Pulmonol 2019;54:1351-3. [DOI: 10.1002/ppul.24412] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Scotta MC, Marostica PJ, Stein RT. Pneumonia in Children. Kendig's Disorders of the Respiratory Tract in Children. Elsevier; 2019. pp. 427-438.e4. [DOI: 10.1016/b978-0-323-44887-1.00025-0] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Haggie S, Fitzgerald DA, Pandit C, Selvadurai H, Robinson P, Gunasekera H, Britton P. Increasing Rates of Pediatric Empyema and Disease Severity With Predominance of Serotype 3 S. pneumonia: An Australian Single-center, Retrospective Cohort 2011 to 2018. Pediatr Infect Dis J 2019;38:e320-5. [PMID: 31634299 DOI: 10.1097/INF.0000000000002474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
9 Principi N, Esposito S. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines. Int J Mol Sci 2016;18:E30. [PMID: 28029140 DOI: 10.3390/ijms18010030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
10 Peters RT, Parikh DH, Singh M. Thoracoscopic debridement for empyema thoracis. J Pediatr Surg 2020;55:2187-90. [PMID: 32147236 DOI: 10.1016/j.jpedsurg.2020.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Cornfield DN. Pediatric pulmonary medicine: at the nexus of care and discovery. Curr Opin Pediatr 2018;30:364-5. [PMID: 29553958 DOI: 10.1097/MOP.0000000000000631] [Reference Citation Analysis]
12 Kushner LE, Nieves DJ, Osborne S, Vora H, Arrieta A, Singh J. Oral Antibiotics for Treating Children With Community-Acquired Pneumonia Complicated by Empyema. Clin Pediatr (Phila) 2019;58:1401-8. [DOI: 10.1177/0009922819850494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Goettler D, Streng A, Kemmling D, Schoen C, von Kries R, Rose MA, van der Linden M, Liese JG. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. Vaccine 2020;38:570-7. [PMID: 31735502 DOI: 10.1016/j.vaccine.2019.10.056] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
14 Martínez-Osorio J, García-García JJ, Moraga-Llop F, Díaz A, Hernández S, Solé-Ribalta A, González-Peris S, Izquierdo C, Esteva C, Codina G, Planes AM, Uriona S, Campins M, Ciruela P, Salleras L, Domínguez Á, Muñoz-Almagro C, de Sevilla MF. Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine. An Pediatr (Engl Ed) 2021:S2341-2879(21)00113-7. [PMID: 34238710 DOI: 10.1016/j.anpede.2021.06.005] [Reference Citation Analysis]
15 Ouldali N, Levy C, Minodier P, Morin L, Biscardi S, Aurel M, Dubos F, Dommergues MA, Mezgueldi E, Levieux K, Madhi F, Hees L, Craiu I, Gras Le Guen C, Launay E, Zenkhri F, Lorrot M, Gillet Y, Béchet S, Hau I, Martinot A, Varon E, Angoulvant F, Cohen R. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children. JAMA Pediatr 2019;173:362-70. [PMID: 30715140 DOI: 10.1001/jamapediatrics.2018.5273] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
16 Gupta I, Eid SM, Gillaspie EA, Broderick S, Shafiq M. Epidemiologic Trends in Pleural Infection. A Nationwide Analysis. Ann Am Thorac Soc 2021;18:452-9. [PMID: 33001756 DOI: 10.1513/AnnalsATS.202001-075OC] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Bernaola E, Gil F, Herranz M, Gil-Setas A, Guevara M, Castilla J. Pneumococcal Vaccination and Pneumonia Associated With Pleural Effusion in a Pediatric Population. Pediatr Infect Dis J 2018;37:e87-92. [PMID: 28938258 DOI: 10.1097/INF.0000000000001798] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
18 Kelly MM, Coller RJ, Kohler JE, Zhao Q, Sklansky DJ, Shadman KA, Thurber A, Barreda CB, Edmonson MB. Trends in Hospital Treatment of Empyema in Children in the United States. J Pediatr 2018;202:245-251.e1. [PMID: 30170858 DOI: 10.1016/j.jpeds.2018.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
19 Silva-Costa C, Brito MJ, Pinho MD, Friães A, Aguiar SI, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections., Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015. Emerg Infect Dis 2018;24:1307-14. [PMID: 29912700 DOI: 10.3201/eid2407.180029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
20 Sim JY, Chang LY, Chang TH, Chen JM, Lee PI, Huang LM, Lu CY. Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan. J Formos Med Assoc 2020;119:1608-18. [PMID: 32747171 DOI: 10.1016/j.jfma.2020.07.026] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F, Dommergues MA, Mezgueldi E, Levieux K, Béchet S, Varon E, Cohen R; Pneumonia Study Group ., GPIP (Pediatric Infectious Disease Group) . Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation. J Pediatric Infect Dis Soc 2019;8:474-7. [PMID: 30407519 DOI: 10.1093/jpids/piy103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
22 Carloni I, Ricci S, Rubino C, Cobellis G, Rinaldelli G, Azzari C, de Benedictis FM. Necrotizing pneumonia among Italian children in the pneumococcal conjugate vaccine era. Pediatr Pulmonol 2021;56:1127-35. [PMID: 33442941 DOI: 10.1002/ppul.25270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Eichler N, Joseph L, Megged O, Goldberg S, Picard E. The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children. Eur J Clin Microbiol Infect Dis 2022. [PMID: 34997390 DOI: 10.1007/s10096-021-04386-0] [Reference Citation Analysis]
24 Azzari C, Serranti D, Nieddu F, Moriondo M, Casini A, Lodi L, de Benedictis FM, De Vitis E, Cavone F, Cortimiglia M, Indolfi G, Lombardi E, Carloni I, Cutrera R, Lucenteforte E, Resti M, Ricci S. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018. Vaccine 2019;37:2704-11. [PMID: 30981627 DOI: 10.1016/j.vaccine.2019.04.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
25 Rix-Trott K, Byrnes CA, Gilchrist CA, Matsas R, Walls T, Voss L, Mahon C, Dickson NP, Reed P, Best EJ. Surveillance of pediatric parapneumonic effusion/empyema in New Zealand. Pediatr Pulmonol 2021;56:2949-57. [PMID: 34232567 DOI: 10.1002/ppul.25564] [Reference Citation Analysis]
26 Hoshino T, Nishima D, Enseki M, Umehara N, Fukasawa C, Ishiwada N. Pediatric Parapneumonic Effusion/Pleural Empyema in Japan: A Nationwide Survey. Pediatr Infect Dis J 2022;41:20-3. [PMID: 34862346 DOI: 10.1097/INF.0000000000003353] [Reference Citation Analysis]
27 Martínez-Osorio J, García-García JJ, Moraga-Llop F, Díaz A, Hernández S, Solé-Ribalta A, González-Peris S, Izquierdo C, Esteva C, Codina G, Planes AM, Uriona S, Campins M, Ciruela P, Salleras L, Domínguez Á, Muñoz-Almagro C, de Sevilla MF. [Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine]. An Pediatr (Engl Ed) 2021:S1695-4033(21)00206-X. [PMID: 34217675 DOI: 10.1016/j.anpedi.2021.05.018] [Reference Citation Analysis]
28 Tracy MC, Mathew R. Complicated pneumonia: current concepts and state of the art. Curr Opin Pediatr 2018;30:384-92. [PMID: 29528891 DOI: 10.1097/MOP.0000000000000619] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
29 Díaz‐conradi A, Hernández S, García‐garcía JJ, Muñoz‐almagro C, Moraga‐llop F, Ciruela P, Izquierdo C, Campins M, de Sevilla MF, González‐peris S, Uriona S, Martínez‐osorio J, Solé‐ribalta A, Codina G, Esteva C, Planes AM, Soldevila N, Salleras L, Domínguez A. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era. Pediatr Pulmonol 2019;54:517-24. [DOI: 10.1002/ppul.24279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
30 Strachan R, Homaira N, Beggs S, Bhuiyan MU, Gilbert GL, Lambert SB, Macartney K, Marshall H, Martin AC, McCallum GB, McCullagh A, McDonald T, McIntyre P, Oftadeh S, Ranganathan S, Suresh S, Wainwright CE, Wilson A, Wong M, Snelling T, Jaffé A. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax 2021;76:487-93. [PMID: 33504566 DOI: 10.1136/thoraxjnl-2020-216032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
31 Moore PE, Boyer D, Perkins R, Katz ES, Castro-Codesal ML, MacLean JE, Akil N, Esther CR Jr, Kaslow J, Lewis TC, Krone KA, Quizon A, Simpson R, Benscoter D, Spielberg DR, Melicoff E, Kuklinski CA, Blatter JA, Dy J, Rettig JS, Horani A, Gross J. American Thoracic Society 2019 Pediatric Core Curriculum. Pediatr Pulmonol 2019;54:1880-94. [PMID: 31456278 DOI: 10.1002/ppul.24482] [Reference Citation Analysis]
32 Molloy MJ, Thomson JE. A complicated decision: Empiric antibiotics in children with complicated pneumonia. Journal of Hospital Medicine. [DOI: 10.1002/jhm.2738] [Reference Citation Analysis]
33 Esposito S, Dal Canto G, Caramia MR, Fainardi V, Pisi G, Principi N. Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age. Expert Rev Anti Infect Ther 2021;:1-7. [PMID: 33971782 DOI: 10.1080/14787210.2021.1927710] [Reference Citation Analysis]